Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures FTSE (0.05%), DAX (0.17%), CAC40 +0.41%

Oct 01 ,2025

  • Synopsis

    • European equity markets are set for a mixed open amidst mixed Asian equities Wednesday. Japan weakening while semis driving gains in Taiwan and South Korea. BHP.AU-US weighing on ASX amid China tensions. Greater China markets closed for Golden Week holiday. S&P 500 futures extending losses ahead of US government shutdown.

    • EU leaders will meet for an informal European Council in Copenhagen, EU's von der Leyen among the participants.

    • Deadline for companies on the Norwegian continental shelf (NCS) to nominate blocks for the 26th licensing round on the NCS. Nordic energy ministers meet in Helsinki, the central topics at the meeting are energy security in the Nordic countries and cross-border cooperation.

    • In central banks, ECB's Elderson speech at 9:30CET at the ECB Industry Dialogue on Climate and nature risk management: Taking stock and looking ahead. ECB's de Guindos one-one interview and panelist at 9:55CET at POLITICO Competitive Europe Summit. Bundesbank's Mauderer speech at 11:00CET at bank's regional office in Hamburg, Mecklenburg-West Pomerania and Schleswig-Holstein. BOE's Mann in conversation at 10:55BST at the Bloomberg Women, Money & Power conf whilst SNB quarterly bulletin published at 15:00CET. ECMI, NBS, CEPS, and SUERF host event (through Thu) title Financial deepening - how can we finance productivity growth and transition in small and medium sized economies?.

    • France, Italy and Spain Sep new car registrations are due to be released.

    • Macro data due include Italy, Norway, Spain, Sweden, Switzerland Sep manufacturing PMI with final reads for Eurozone, France, Germany, UK, Switzerland Aug retail sales, Eurozone Sep preliminary CPI, Netherlands Sep preliminary CPI, Aug retail sales, Finland Sep preliminary HICP, UK Sep house price index - Nationwide, Austria Sep preliminary CPI, unemployment rate, Ireland Sep unemployment rate, Portugal Aug unemployment rate.

    • In earnings, Aperam (APAM.NA) confirmed Q3 outlook ahead of its Q3 earrings release on 7-Nov. In the Nordics, Ambu (AMBU.B.DC) announced updated long-term financial targets through FY 2029/30 ahead of Capital Markets Day whilst Modern Times Group MTG (MTG.B.SS) released plans for new divisional structure, operational leadership changes and agenda for CMD on 9-Oct. Banco de Sabadell (SAB.SM) raised FY25 shareholder remuneration target to ~€1.45B vs prior €1.3B; cites positive evolution of the business.

    • Also due to release updates today are Danske Bank (DANSKE.DC), UK: Greggs (GRG.LN) and Topps Tiles (TPT.LN).

  • Politics/Macro/World News

    • BoE deputy governor Breeden says recent inflation hump unlikely to lead to additional inflationary pressure

    • Russia's hybrid war is 'only the beginning', warns Danish PM - FT

    • Netherlands Sep Preliminary CPI +3.3% y/y vs consensus +2.8% and prior +2.8%

    • Netherlands Aug Retail Sales +3.6% y/y vs consensus +4.5% and revised +4.3% from +5.0%

  • Top company news

    • Earnings/updates

      • Benelux:

        • APAM.NA (Aperam) -- confirms Q3 outlook ahead of its Q3 earrings release on 7-Nov

        • OXUR.BB (Oxurion) -- reports H1 net income (€1.2M) vs year-ago (€3.0M)

      • DACHs:

        • B8FK.GR (Biofrontera AG) -- issues correction notice; clarifies FY EBITDA guidance €1.5-3.5M vs incorrectly stated €0.5-1.5M

      • France:

        • NANO.FP (Nanobiotix) -- reports H1 net income (€5.4M) vs year-ago (€21.9M)

        • AB.FP (AB Science) -- announces delay in publication of 1H25 report

        • ALICA.FP (ICAPE Holding) -- reports H1 net income €0.8M vs year-ago €1.0M; reaffirms 2026 guidance

      • Nordics:

        • AMBU.B.DC (Ambu) -- announces updated long-term financial targets through FY 2029/30 ahead of Capital Markets Day

        • MTG.B.SS (Modern Times Group MTG) -- announces plans for new divisional structure, operational leadership changes and agenda for CMD on 9-Oct

        • SKIS.B.SS (SkiStar) -- reports Q4 EPS (SEK3.35) vs FactSet (SEK3.58) [4 est, (SEK3.65)-(3.48)]

        • NETEL.SS (Netel Holding) -- H1 Update: Netel is impacted by impairments in three subsidiaries acquired in 2021-2022

        • ANDF.NO (Andfjord Salmon Group) -- smolt release update; 350K smolt at average weight of ~180gms released into pool at Kvalnes

      • Southern Europe:

        • SAB.SM (Banco de Sabadell) -- raises FY25 shareholder remuneration target to ~€1.45B vs prior €1.3B; cites positive evolution of the business

        • TLGO.SM (Talgo) -- reports H1 net income (€65.7M) vs year-ago €14.6M

        • GEKTERNA.GA (GEK Terna) -- reports final H1 earning in line with preliminary release: net income €68.3M

    • M&A

      • TTE.FP (TotalEnergies) -- Vår Energi acquires TotalEnergies' ownership interest in the Ekofisk PPF development project; financial details weren't disclosed

      • MUX.GR (Mutares) -- signs agreement to acquire Achleitner Fahrzeugbau GmbH

      • NOTE.SS (NOTE) -- agrees to acquire Kasdon Group for an initial £28.2M on a cash/debt-free basis

      • ACKB.BB (Ackermans & Van Haaren) -- announces Delen Private Bank finalises acquisitions of Petram and Servatus

      • TTE.FP (TotalEnergies) -- divests 50% of a 270 MW portfolio in France to Eiffel Investment Group

      • ROO.LN (Deliveroo) -- announces Court sanctions Scheme in relation to the offer from DoorDash; Scheme expected to become effective on 2-Oct

      • SAB.SM (Banco de Sabadell) -- rejects BBVA's revised hostile tender offer

      • GF.SW (Georg Fischer) -- completes the acquisition of VAG Group

      • AED.BB (Aedifica) -- provides update on the progress of Belgian Competition Authority's review of / Cofinimmo deal

      • ANTIN.FP (Antin Infrastructure Partners) -- is acquiring a majority stake in Swiftair Group. Terms were not disclosed

      • FEN.LN (Frenkel Topping Group) -- Frenkel Topping Group announces recommended offer from Irwell Bidco

      • NRDF.DC (Nordfyns Bank) -- and Middelfart Sparekasse enter into an agreement to merge

      • GIVN.SW (Givaudan) -- to acquire Belle Aire Creations; term not disclosed

      • SIKA.SW (Sika Group) -- Sika acquires Danish mortar company Marlon Tørmørtel A/S; price not disclosed

      • BAMI.IM (Banco BPM) -- Credit Agricole has discussed with Italian government conditions for possible merger between its Italian unit and Banco BPM - Reuters (30-Sep, 17:11 CET)

      • COFB.BB (Cofinimmo) -- completes Edegem office divestment for €7M

      • OBEL.BB (Orange Belgium) -- announces signing of pledge agreement and Letter of Consent and release with Enodia in connection with the demerger of VOO

      • ACE.IM (ACEA) -- completes sale of high-voltage electricity grid to TERNA Limited

      • THEP.FP (Thermador Groupe) -- announces acquisition of Quilinox company

      • CS.SS (Coinshares International) -- to acquire Bastion Asset Management Limited; terms undisclosed

      • VAHN.SW (Vaudoise Assurances Holding) -- Vaudoise acquires Ecofin Investment Consulting AG

      • NRG.FP (NRJ Group) -- completes sale of Chérie 25 channel to the CMA Media Group

      • HCO.FP (HighCo) -- announces acquisition of Sogec and BudgetBox promotion activities finalized

      • Sembcorp in talks to acquire Alinta Energy- The Australian

    • Healthcare

      • NOVN.SW (Novartis) -- Novartis' Rhapsido (remibrutinib) receives FDA approval as reported on FDA website

      • NOVN.SW (Novartis) -- issues press release regarding FDA approval for Rhapsido (remibrutinib)

      • SAN.FP (Sanofi) -- the target of raid by EU antitrust regulators over suspected "anticompetitive disparagement" - Bloomberg (30-Sep, intraday)

      • PHARM.NA (Pharming Group) -- announces FDA acceptance and Priority Review of supplemental New Drug Application for leniolisib in children with APDS aged 4 to 11 years

      • CANTA.SS (Cantargia) -- presents two posters on the potential of nadunolimab in PDAC at AACR conference

      • OSE.FP (OSE Immunotherapeutics) -- board elects Markus Cappel as chairman

    • Other

      • ALCAR.FP (CARMAT) -- Provides an Update on the Ongoing Receivership Procedure

      • AG1.AV (Auto1 Group) -- announces CFD Markus Boser will be stepping down; appoints Christian Wallentin as new CFO effective 1-Jan-26

      • VK.FP (Vallourec) -- secures new order with Petrobras for SUBMAGNTICO free flow

      • MB.IM (Mediobanca) -- Monte Paschi rumoured to appoint former Italian econ-min Vittorio Grilli as new Mediobanca president -- Reuters

      • MULTI.NO (Multiconsult) -- announces changes to the executive management team effective from 1-Oct; search for new CEO continues

      • LDO.IM (Leonardo) -- awarded FREIA contract to provide advanced cybersecurity services to the European Commission

      • DEC.LN (Diversified Energy Co.) -- announces proposed move of primary listing to the NYSE

      • HTWS.LN (Helios Towers) -- launches $300M convertible bond tender

      • IPCO.SS (International Petroleum Corp) -- completes annual normal course issuer bid

      • DTE.GR (Deutsche Telekom) -- to begin fourth tranche of up-to-€2B 2025 buyback program today

      • VWS.DC (Vestas Wind Systems) -- announces five orders for a total of 346 MW

      • HO.FP (Thales) -- proposes interim ordinary cash dividend of €0.95 per share for the current 2025 financial year

      • ACA.FP (Credit Agricole) -- Crédit Agricole launches share repurchase program for up to 22.9M ordinary shares

      • SWED.A.SS (Swedbank) -- has been informed of SREP 2025 decision by Swedish Financial Supervisory Authority

      • SEB.A.SS (Skandinaviska Enskilda Banken) -- SEB receives result of the Swedish FSA's annual Supervisory Review and Evaluation Process

      • ARCAD.NA (ARCADIS) -- announces €175M share buyback program

      • GL9.ID (Glanbia) -- Glanbia's main holder Tirlán Co-Operative to sell up to 17.0M ordinary shares in the company, ~7% of its share capital through private placement; to buy back up to 45% of the Equity Placement shares offered and capped at €100M in value

      • Gladstone Power Station JV confirms that CS Energy has formally notified AEMO of potential retirement of GPS in March 2029

      • Lifeway and Danone sign cooperation agreement

      • MPA Delivery Partners awarded a $665M, 4.5-year contract extension

  • Key rating changes

    • Upgrades:

      • IHG.LN (InterContinental Hotels Group) -- equal-weight from underweight at Morgan Stanley

      • PHNX.LN (Phoenix Group Holdings) -- outperform from underperform at Mediobanca

  • Data

    • Nikkei (0.86%) to 44544.13

    • Hang Seng +0.00% to 26855.56

    • Shanghai Composite +0.00% to 3882.78

    • S&P futures (32.8) vs prior close of 6738.8

    • €-$ +0.0021 or +0.18% to 1.1755

    • $-¥ (0.36) or (0.24%) to 147.57

    • €-¥ (0.11) or (0.06%) to 173.46

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE